Table 2.
Endpointe | Studies assessing the endpoint of interest, n | Studies defining the endpoint of interest, n |
---|---|---|
Mortality | ||
Overall mortality | 29 | 27a |
Mortality from liver failure | 3 | 3 |
Morbidity | ||
Overall morbidity | 43 | 33b |
Severe morbidity | 7 | 6 |
Organ dysfunction | 1 | 1 |
Major infectious morbidity | 1 | 1 |
Intraoperative complications | ||
Operation time | 1 | 1 |
Intraoperative blood transfusion | 1 | 1 |
Liver-related complications | ||
Hepatobiliary complications | 1 | 1 |
Haemorrhage | 1 | 1 |
Biliary complications | 1 | 1 |
Liver failure | 21 | 18c |
Bile leak | 5 | 4d |
Biliary complications | 1 | 1 |
Ascites | 1 | 1 |
Acute renal failure | 1 | 1 |
Pulmonary complications | 1 | 1 |
Pleural effusion | 1 | 1 |
Pneumonia | 1 | 1 |
Pulmonary embolism | 1 | 1 |
Infection | 6 | 6 |
Surgical site infection | 2 | 2 |
Intra-abdominal abscess | 1 | 1 |
Blood transfusion during hospital stay | 1 | 1 |
Systemic complications | 1 | 1 |
Postoperative complications | ||
Ventilation for >48 h | 1 | 1 |
Reoperation | 1 | 1 |
Length of stay | 5 | 5 |
Six definitions of mortality were used, including 30-, 60- and 90-day, operative and in-hospital mortality and any death after surgery.
Multiple definitions of morbidity (when morbidity was defined) were used depending on severity (major as opposed to minor, specific, serious, resulting in organ failure, graded 3–5 on a scale of 1–5) origin (medical, surgical, both or unspecified) and timing (30-, 60- or 90-day, operative, in-hospital and after surgery).
Liver failure was defined by the association of many parameters including serum bilirubin, serum lactate, international normalized ratio, prothrombin time, encephalopathy, ascites, pleural effusion, varix, and time and delay of occurrence.
Bile leak was defined by the association of many parameters including level of bilirubin and delay in occurrence.
Some studies analysed one or more endpoints of interest.